Arab Finance: The Tenth of Ramadan for Pharmaceuticals Industries and Diagnostic Reagents (Rameda) (RMDA) has become a member of the United Nations (UN) Global Compact, the biggest global initiative to encourage corporates to adopt sustainability standards, according to a press release on June 20th.
Rameda is now one of more than 6,000 participants from 135 countries in the initiative, which targets following the international principles of human rights, environment protection, and combating corruption.
The UN Global Compact aims at motivating companies across various economic sectors to enhance their businesses to achieve the objectives of sustainable development.
Rameda is an Egypt-based pharmaceutical company that manufactures both human and veterinary pharmaceuticals.
It operates three fully independent factories at its plant, including 20 production lines capable of producing a wide range of general medicinal forms, namely eye drops, solid dosage forms, syrups, blow-fill-seal, and lyophilized vials, among others.